P38-A108 Optimization of the triple HEC staining for laboratory assessment of DMEK graft quality.
Journal
BMJ open ophthalmology
ISSN: 2397-3269
Titre abrégé: BMJ Open Ophthalmol
Pays: England
ID NLM: 101714806
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
medline:
23
8
2023
pubmed:
22
8
2023
entrez:
21
8
2023
Statut:
ppublish
Résumé
The quality of the endothelial graft is critical to the success of DMEK and to the survival time of the graft. The peeling technique, preservation method, and skill level of graft preparers need to be evaluated and validated. The most reliable method of evaluation is the viability test based on a triple staining of Hoechst- Ethidium-Calcein AM (H-E-C) which allows the determination of the total number of viable cells on the graft. However, this test has some shortcomings for DMEK grafts: 1) The undesirable fluorescence of the Calcein AM stain prevents accurate viability analysis, especially in cases where the graft is attached to the cornea for preservation; 2) Incompatibility with immunofluorescence (IF) that could provide additional information. The objective of this study is to develop technical tricks to overcome these drawbacks. Two strategies were employed to improve Calcein AM staining: 1. Increase the specific fluorescence intensity by changing the diluent and the concentration of Calcein AM; 2. Decrease undesired fluorescence from keratocytes by adding Trypan Blue (BT). In order to combine the IF after the HEC test, an extension wash in PBS was performed. Calcein AM at 4µM diluted in OptiMEM increased fluorescence intensity 3-fold (p=0.0017, n=5) compared with conventional staining at 2µM in PBS. BT decreased the undesired fluorescence of Calcein and thus optimized count variability between different operators by 42% (p=0.0027, n=10) and saved 40% (p=0.0002, n=10) of count time. To perform IF after HEC, prolonged washing in PBS is an effective method to remove residual Calcein fluorescence and allows release of the FITC/Alexa 488 filter. This study provides effective technical tips for optimizing the endothelial viability assay using Calcein AM and for performing IF after the viability assay.
Identifiants
pubmed: 37604568
pii: bmjophth-2023-EEBA.37
doi: 10.1136/bmjophth-2023-EEBA.37
doi:
Substances chimiques
fluorexon
V0YM2B16TS
Fluoresceins
0
Fluorescent Dyes
0
Ethidium
EN464416SI
calcein AM
148504-34-1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
A15-A16Informations de copyright
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.